Medicinal foodstuffs. XXXIV.1) Structures of new prenylchalcones and prenylflavanones with TNF-αand aminopeptidase N inhibitory activities from Boesenbergia rotunda

Chemical and Pharmaceutical Bulletin

Volumn 56, Issue 7, 2008, Pages 956-962

  Morikawa, Toshio ^a   Funakoshi, Kanako ^b   Ninomiya, Kiyofumi ^a   Yasuda, Daisuke ^b   Miyagawa, Katsutoshi ^b   Matsuda, Hisashi ^b   Yoshikawa, Masayuki ^a,b  

^a KINKI UNIVERSITY   (Japan)

^b KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Aminopeptidase N inhibitor; Boesenbergia rotunda; Krachaizin; Rotundaflavone; Tumor necrosis factor inhibitory activity; Zingiberaceae

Indexed keywords

2,6 DIHYDROXY 4 METHOXYDIHYDROCHALCONE; 4 HYDROXYPANDURATIN A; ALPINETIN; CARDAMONIN; CHALCONE DERIVATIVE; GERANYL 2,4 DIHYDROXY 6 PHENYLBENZOATE; ISOPANDURATIN A; KRACHAIZIN A; KRACHAIZIN B; MICROSOMAL AMINOPEPTIDASE; PRENYLCHALCONE; PRENYLFLAVANONE DERIVATIVE; ROTUNDAFLAVONE IA; ROTUNDAFLAVONE IB; ROTUNDAFLAVONE IIA; ROTUNDAFLAVONE IIB; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BOESENBERGIA ROTUNDA; CONTROLLED STUDY; CYTOTOXICITY; DRUG ISOLATION; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; IC 50; NONHUMAN; RHIZOME; ZINGIBERACEAE;

ANTIGENS, CD13; APOPTOSIS; CHALCONES; FLAVANONES; PROTEASE INHIBITORS; TUMOR NECROSIS FACTOR-ALPHA; ZINGIBERACEAE;

EID: 46749141331     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.56.956     Document Type: Article

References (34)

1. Part XXXIII: Yoshikawa M., Morikawa T., Funakoshi K., Ochi M., Pongpiriyadacha Y., Matsuda H., Heterocycles, 75 (2008), in press.
2. Thaingburanatham V., "Dictionary of Thai Medicinal Plants," 2nd ed., Suriyaban Publisher, Bankok, 1993, p. 880.
3. Saralamp P., Chuakul W., Temsiririrkkul R., Clayton T., "Medicinal Plants in Thailand," Vol. I, Amarin Printing and Publishing Public Co., Ltd., Bankok, 1996, p. 49.
4. Yoshikawa M., Morikawa T., Nakano K., Pongpiriyadacha Y., Murakami T., Matsuda H., J. Nat. Prod., 65, 1638-1642 (2002).
5. Yoshikawa M., Pongpiriyadacha Y., Kishi A., Kageura T., Wang T., Morikawa T., Matsuda H., Yakugaku Zasshi, 123, 871-880 (2003).
6. Morikawa T., Kishi A., Pongpiriyadacha Y., Matsuda H., Yoshikawa M., J. Nat. Prod., 66, 1191-1196 (2003).
7. Kishi A., Morikawa T., Matsuda H., Yoshikawa M., Chem. Pharm. Bull., 51, 1051-1055 (2003).
8. Matsuda H., Pongpiriyadacha Y., Morikawa T., Ochi M., Yoshikawa M., Eur. J. Pharmacol., 471, 59-67 (2003).
9. Matsuda H., Morikawa T., Managi H., Yoshikawa M., Bioorg. Med. Chem. Lett., 13, 3197-3202 (2003).
10. Matsuda H., Ando S., Morikawa T., Kataoka S., Yoshikawa M., Bioorg. Med. Chem. Lett., 15, 1949-1953 (2005).
11. Ando S., Matsuda H., Morikawa T., Yoshikawa M., Bioorg. Med. Chem., 13, 3289-3294 (2005).
12. Morikawa T., Ando S., Matsuda H., Kataoka S., Muraoka O., Yoshikawa M., Chem. Pharm. Bull., 53, 625-630 (2005).
13. Morikawa T., Matsuda H., Yamaguchi I., Pongpiriyadacha Y., Yoshikawa M., Planta Med., 70, 152-159 (2004).
14. Matsuda H., Ninomiya K., Morikawa T., Yasuda D., Yamaguchi I., Yoshikawa M., Bioorg. Med. Chem. Lett., 18, 2038-2042 (2008).
15. Matsuda H., Tewtrakul S., Morikawa T., Nakamura A., Yoshikawa M., Bioorg. Med. Chem., 12, 5891-5898 (2004).
16. Matsuda H., Morikawa T., Xu F., Ninomiya K., Yoshikawa M., Planta Med., 70, 1201-1209 (2004).
17. Morikawa T., Xu F., Matsuda H., Yoshikawa M., Chem. Pharm. Bull., 54, 1530-1534 (2006).
18. Matsuda H., Yoshida K., Miyagawa K., Asao Y., Takayama S., Nakashima S., Xu F., Yoshikawa M., Bioorg. Med. Chem., 15, 1539-1546 (2007).
19. Yoshikawa M., Xu F., Morikawa T., Pongpiriyadacha Y., Nakamura S., Asao Y., Kumahara A., Matsuda H., Chem. Pharm. Bull., 55, 308-316 (2007).
20. 13C-NMR spectra of 1a-4b were assigned with the aid of distortionless enhancement by polarization transfer (DEPT), double quantum filter correlation spectroscopy (DQF COSY), heteronuclear multiple quantum coherence (HMQC), and heteronuclear multiple bond connectivity (HMBC) experiments.
21. Gu J.-Q., Park E. J., Vigo J. S., Graham J. G., Fong H. H. S., Pezzuto J. M., Kinghorn A. D., J. Nat. Prod., 65, 1616-1620 (2002).
22. Li N., Morikawa T., Matsuda H., Ninomiya K., Li X., Yoshikawa M., Heterocycles, 71, 1193-1201 (2007).
23. Matsuda H., Morikawa T., Toguchida I., Harima S., Yoshikawa M., Chem. Pharm. Bull., 50, 972-975 (2002).
24. Yoshikawa M., Xu F., Morikawa T., Ninomiya K., Matsuda H., Bioorg. Med. Chem. Lett., 13, 1045-1049 (2003).
25. Wang Y., Singh R., Lefkowitch J. H., Rigoli R. M., Czaja M. J., J. Biol. Chem., 281, 15258-15267 (2006).
26. Tilg H., Day C. P., Nat. Clin. Pract. Gastroenterol. Hapatol., 4, 24-34 (2007).
27. Seronello S., Sheikh M. Y., Choi J., Free Radic. Biol. Med., 43, 869-882 (2007).
28. Kouroku Y., Fujita E., Jimbo A., Mukasa T., Tsuru T., Momoi M. Y., Momoi T., Biochem. Biophys. Res. Commun., 270, 972-977 (2000).
29. Each value represents the mean±S.E.M. (n=4). Significantly different from the control, *p<0.05, **p<0.01.
30. Look A. T., Ashmum R. A., Shapiro L. H., Peiper S. C., J. Clin. Invest., 83, 1299-1307 (1989).
31. Saiki I., Fujii H., Yoneda J., Abe F., Nakajima M., Tsuruo T., Azuma I., Int. J. Cancer, 54, 137-143 (1993).
32. Pasqualini R., Koivunen E., Kain R., Lahdenranta J., Sakamoto M. M., Stryhn A., Ashmum R. A., Shapiro L. H., Arap W., Ruoslahti E., Cancer Res., 60, 722-727 (2000).
33. Morikawa T., Xie H., Wang T., Matsuda H., Yoshikawa M., Chem. Biodivers., 5 (2008), in press.
34. Shim J. S., Kim J. H., Cho H. Y., Yum Y. N., Kim S. H., Park H.-J., Shim B. S., Choi S. H., Kwon H. J., Chem. Biol., 10, 695-704 (2003).